Article
Mechanistic analysis of compounds that modulate VEGF-A splicing in podocytes with therapeutic potential for diabetic nephropathy
2025-12-01
Abstract excerpt
Vascular endothelial growth factor A (VEGF-A) has an alternatively spliced variant, VEGF-A165b, formed when a distal 3’ splice site in exon 8 is selected. The anti-angiogenic and anti-permeability VEGF-A165b has reno-protective properties and has been shown to rescue kidney function in diabetic nephropathy (DN) mouse models (PMID 25542969). We previously identified three new compounds that can increase the express...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 77a5658f-0e40-5c44-8f2d-abefc1e61518
- DOI
- 10.1101/2025.11.27.690981
